AI-Based Health Screening Company iHealthScreen Announces Q&A Webinar
June 27, 2023 15:16 ET
|
iHealthScreen Inc.
RICHMOND HILL, N.Y., June 27, 2023 (GLOBE NEWSWIRE) -- via IBN -- AI-based health screening company iHealthScreen today announces it will host an exclusive Q&A webinar on July 11 at 9 a.m. PDT....
Dr. SriniVas R. Sadda Named 2023-2024 ARVO President Elect
June 27, 2023 09:00 ET
|
Doheny Eye Institute
PASADENA, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that SriniVas R. Sadda, MD, was named President Elect of...
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
June 27, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, June 26, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
AI-Based Health Screening Company iHealthScreen Reaches $150K in Investments
June 26, 2023 20:25 ET
|
iHealthScreen Inc.
RICHMOND HILL, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- AI-based health screening company iHealthScreen recently announced raising $150,000 in investments on StartEngine. To date, the company has...
Global Ophthalmics Partnering Deal Trends, Players and Financials Report 2023
June 06, 2023 03:38 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Ophthalmics Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.Global...
Global Ophthalmoscopes Market Report 2023: Sector is Expected to Reach $408.7 Million by 2030 at a CAGR of 6.6%
June 02, 2023 04:43 ET
|
Research and Markets
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmoscopes Market Size, Share & Trends Analysis Report By Type (Direct, Indirect), By Application (Diabetic Retinopathy, Macular Degeneration,...
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
June 02, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, 2 June 2023. Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral,...
Dr. Kaustabh Ghosh Recognized With Prestigious Catalyst Award for Innovative Age-Related Macular Degeneration Research
June 01, 2023 09:06 ET
|
Doheny Eye Institute
PASADENA, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that Kaustabh Ghosh, PhD, was recently recognized by...
Kinarus Therapeutics Group Reports 2022 Annual Results
May 31, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022Clinical efforts re-focused on developing KIN001 for original indications IPF and wet AMDCDIM CHF1.5...
Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
May 11, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, May 10, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...